CA1146821A - Sustained drug release device - Google Patents
Sustained drug release deviceInfo
- Publication number
- CA1146821A CA1146821A CA000339311A CA339311A CA1146821A CA 1146821 A CA1146821 A CA 1146821A CA 000339311 A CA000339311 A CA 000339311A CA 339311 A CA339311 A CA 339311A CA 1146821 A CA1146821 A CA 1146821A
- Authority
- CA
- Canada
- Prior art keywords
- sheet
- erodable
- rumen
- medicament
- polymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000013269 sustained drug release Methods 0.000 title 1
- 210000004767 rumen Anatomy 0.000 claims abstract description 36
- 239000003814 drug Substances 0.000 claims abstract description 33
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 claims abstract description 15
- 239000005038 ethylene vinyl acetate Substances 0.000 claims abstract description 13
- 229920003023 plastic Polymers 0.000 claims abstract description 11
- 239000004033 plastic Substances 0.000 claims abstract description 11
- 230000000507 anthelmentic effect Effects 0.000 claims abstract description 9
- 241000282849 Ruminantia Species 0.000 claims abstract description 6
- 230000000717 retained effect Effects 0.000 claims abstract description 4
- 229920000642 polymer Polymers 0.000 claims description 22
- 239000000463 material Substances 0.000 claims description 16
- 229920003176 water-insoluble polymer Polymers 0.000 claims description 5
- 238000005096 rolling process Methods 0.000 claims description 4
- 230000003628 erosive effect Effects 0.000 abstract description 6
- 239000000853 adhesive Substances 0.000 abstract description 3
- 230000001070 adhesive effect Effects 0.000 abstract description 3
- YRWLZFXJFBZBEY-UHFFFAOYSA-N N-(6-butyl-1H-benzimidazol-2-yl)carbamic acid methyl ester Chemical compound CCCCC1=CC=C2N=C(NC(=O)OC)NC2=C1 YRWLZFXJFBZBEY-UHFFFAOYSA-N 0.000 description 24
- 229950007337 parbendazole Drugs 0.000 description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 241001494479 Pecora Species 0.000 description 11
- 229920001577 copolymer Polymers 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 229920000609 methyl cellulose Polymers 0.000 description 9
- 239000001923 methylcellulose Substances 0.000 description 9
- 235000010981 methylcellulose Nutrition 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- 229940079593 drug Drugs 0.000 description 8
- 150000003839 salts Chemical class 0.000 description 8
- 229920002261 Corn starch Polymers 0.000 description 7
- 229920002472 Starch Polymers 0.000 description 7
- 239000008107 starch Substances 0.000 description 7
- 235000019698 starch Nutrition 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 6
- 229940124339 anthelmintic agent Drugs 0.000 description 6
- 239000000921 anthelmintic agent Substances 0.000 description 6
- 229920000159 gelatin Polymers 0.000 description 6
- 235000019322 gelatine Nutrition 0.000 description 6
- 241000283690 Bos taurus Species 0.000 description 5
- HLFSDGLLUJUHTE-SNVBAGLBSA-N Levamisole Chemical compound C1([C@H]2CN3CCSC3=N2)=CC=CC=C1 HLFSDGLLUJUHTE-SNVBAGLBSA-N 0.000 description 5
- 239000008120 corn starch Substances 0.000 description 5
- 229960001614 levamisole Drugs 0.000 description 5
- 238000013268 sustained release Methods 0.000 description 5
- 239000012730 sustained-release form Substances 0.000 description 5
- 229910000831 Steel Inorganic materials 0.000 description 4
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- -1 citrate and tartrate Chemical class 0.000 description 4
- 239000010959 steel Substances 0.000 description 4
- NVEPPWDVLBMNMB-SNAWJCMRSA-N 1-methyl-2-[(e)-2-(3-methylthiophen-2-yl)ethenyl]-5,6-dihydro-4h-pyrimidine Chemical compound CN1CCCN=C1\C=C\C1=C(C)C=CS1 NVEPPWDVLBMNMB-SNAWJCMRSA-N 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- 239000001828 Gelatine Substances 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 206010067171 Regurgitation Diseases 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 229960005121 morantel Drugs 0.000 description 3
- 230000010355 oscillation Effects 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 239000001856 Ethyl cellulose Substances 0.000 description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 235000019325 ethyl cellulose Nutrition 0.000 description 2
- 229920001249 ethyl cellulose Polymers 0.000 description 2
- 235000010944 ethyl methyl cellulose Nutrition 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 230000002028 premature Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 229960005134 pyrantel Drugs 0.000 description 2
- YSAUAVHXTIETRK-AATRIKPKSA-N pyrantel Chemical compound CN1CCCN=C1\C=C\C1=CC=CS1 YSAUAVHXTIETRK-AATRIKPKSA-N 0.000 description 2
- IKXCHOUDIPZROZ-LXGUWJNJSA-N (2r,3r,4r,5s)-6-(ethylamino)hexane-1,2,3,4,5-pentol Chemical class CCNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO IKXCHOUDIPZROZ-LXGUWJNJSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- 125000000134 2-(methylsulfanyl)ethyl group Chemical group [H]C([H])([H])SC([H])([H])C([H])([H])[*] 0.000 description 1
- YWDWYOALXURQPZ-CYBMUJFWSA-N 2-methyl-n-[3-[(6s)-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazol-6-yl]phenyl]propanamide Chemical compound CC(C)C(=O)NC1=CC=CC([C@@H]2N=C3SCCN3C2)=C1 YWDWYOALXURQPZ-CYBMUJFWSA-N 0.000 description 1
- RFAYUIIWPKWNKY-UHFFFAOYSA-N 6-(3-nitrophenyl)-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole Chemical compound [O-][N+](=O)C1=CC=CC(C2N=C3SCCN3C2)=C1 RFAYUIIWPKWNKY-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- HMCCXLBXIJMERM-UHFFFAOYSA-N Febantel Chemical compound C1=C(NC(NC(=O)OC)=NC(=O)OC)C(NC(=O)COC)=CC(SC=2C=CC=CC=2)=C1 HMCCXLBXIJMERM-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- RAOCRURYZCVHMG-UHFFFAOYSA-N N-(6-propoxy-1H-benzimidazol-2-yl)carbamic acid methyl ester Chemical compound CCCOC1=CC=C2N=C(NC(=O)OC)NC2=C1 RAOCRURYZCVHMG-UHFFFAOYSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 229930191764 Sparin Natural products 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229960002669 albendazole Drugs 0.000 description 1
- HXHWSAZORRCQMX-UHFFFAOYSA-N albendazole Chemical compound CCCSC1=CC=C2NC(NC(=O)OC)=NC2=C1 HXHWSAZORRCQMX-UHFFFAOYSA-N 0.000 description 1
- 201000008680 babesiosis Diseases 0.000 description 1
- 239000013533 biodegradable additive Substances 0.000 description 1
- 239000003181 biological factor Substances 0.000 description 1
- 229950000536 butamisole Drugs 0.000 description 1
- 229960003475 cambendazole Drugs 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229940001468 citrate Drugs 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 239000003224 coccidiostatic agent Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 229960003974 diethylcarbamazine Drugs 0.000 description 1
- RCKMWOKWVGPNJF-UHFFFAOYSA-N diethylcarbamazine Chemical compound CCN(CC)C(=O)N1CCN(C)CC1 RCKMWOKWVGPNJF-UHFFFAOYSA-N 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000001761 ethyl methyl cellulose Substances 0.000 description 1
- 229960005282 febantel Drugs 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 229960004500 flubendazole Drugs 0.000 description 1
- CPEUVMUXAHMANV-UHFFFAOYSA-N flubendazole Chemical compound C1=C2NC(NC(=O)OC)=NC2=CC=C1C(=O)C1=CC=C(F)C=C1 CPEUVMUXAHMANV-UHFFFAOYSA-N 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 229920001684 low density polyethylene Polymers 0.000 description 1
- 239000004702 low-density polyethylene Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 229960003439 mebendazole Drugs 0.000 description 1
- BAXLBXFAUKGCDY-UHFFFAOYSA-N mebendazole Chemical compound [CH]1C2=NC(NC(=O)OC)=NC2=CC=C1C(=O)C1=CC=CC=C1 BAXLBXFAUKGCDY-UHFFFAOYSA-N 0.000 description 1
- HPDOAWBVXUPAAP-UHFFFAOYSA-N methyl (nz)-n-[[2-[(4-chlorophenyl)methylideneamino]-5-propylsulfanylanilino]-methylsulfanylmethylidene]carbamate Chemical compound COC(=O)/N=C(SC)/NC1=CC(SCCC)=CC=C1N=CC1=CC=C(Cl)C=C1 HPDOAWBVXUPAAP-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229920003087 methylethyl cellulose Polymers 0.000 description 1
- 229940029985 mineral supplement Drugs 0.000 description 1
- 235000020786 mineral supplement Nutrition 0.000 description 1
- JNEZCZPNQCQCFK-UHFFFAOYSA-N n-[4-[2-[2-(4-acetamidophenoxy)ethoxy]ethoxy]phenyl]acetamide Chemical compound C1=CC(NC(=O)C)=CC=C1OCCOCCOC1=CC=C(NC(C)=O)C=C1 JNEZCZPNQCQCFK-UHFFFAOYSA-N 0.000 description 1
- 229950006763 nitramisole Drugs 0.000 description 1
- SGKGVABHDAQAJO-UHFFFAOYSA-N nitroxynil Chemical class OC1=C(I)C=C(C#N)C=C1[N+]([O-])=O SGKGVABHDAQAJO-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- BEZZFPOZAYTVHN-UHFFFAOYSA-N oxfendazole Chemical compound C=1C=C2NC(NC(=O)OC)=NC2=CC=1S(=O)C1=CC=CC=C1 BEZZFPOZAYTVHN-UHFFFAOYSA-N 0.000 description 1
- 229960004454 oxfendazole Drugs 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- QZWHWHNCPFEXLL-UHFFFAOYSA-N propan-2-yl n-[2-(1,3-thiazol-4-yl)-3h-benzimidazol-5-yl]carbamate Chemical compound N1C2=CC(NC(=O)OC(C)C)=CC=C2N=C1C1=CSC=N1 QZWHWHNCPFEXLL-UHFFFAOYSA-N 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- NEMNPWINWMHUMR-UHFFFAOYSA-N rafoxanide Chemical compound OC1=C(I)C=C(I)C=C1C(=O)NC(C=C1Cl)=CC=C1OC1=CC=C(Cl)C=C1 NEMNPWINWMHUMR-UHFFFAOYSA-N 0.000 description 1
- 239000012858 resilient material Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 229960004546 thiabendazole Drugs 0.000 description 1
- WJCNZQLZVWNLKY-UHFFFAOYSA-N thiabendazole Chemical compound S1C=NC(C=2NC3=CC=CC=C3N=2)=C1 WJCNZQLZVWNLKY-UHFFFAOYSA-N 0.000 description 1
- 235000010296 thiabendazole Nutrition 0.000 description 1
- 239000004308 thiabendazole Substances 0.000 description 1
- YFNCATAIYKQPOO-UHFFFAOYSA-N thiophanate Chemical compound CCOC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OCC YFNCATAIYKQPOO-UHFFFAOYSA-N 0.000 description 1
- 201000002311 trypanosomiasis Diseases 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0068—Rumen, e.g. rumen bolus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
- A61D7/00—Devices or methods for introducing solid, liquid, or gaseous remedies or other materials into or onto the bodies of animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
- A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB43555/78 | 1978-11-07 | ||
| GB7843555 | 1978-11-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1146821A true CA1146821A (en) | 1983-05-24 |
Family
ID=10500865
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000339311A Expired CA1146821A (en) | 1978-11-07 | 1979-11-06 | Sustained drug release device |
Country Status (10)
Families Citing this family (50)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2966275D1 (en) * | 1978-11-07 | 1983-11-10 | Beecham Group Plc | Device for oral administration to a ruminant animal |
| DE3067332D1 (en) * | 1979-06-27 | 1984-05-10 | Beecham Group Plc | Veterinary preparations for ruminant animals |
| US4381780A (en) * | 1981-01-19 | 1983-05-03 | Research Corporation | Sustained release delivery system |
| EP0076622A1 (en) * | 1981-10-07 | 1983-04-13 | Beecham Group Plc | Anthelmintics |
| US4563184A (en) * | 1983-10-17 | 1986-01-07 | Bernard Korol | Synthetic resin wound dressing and method of treatment using same |
| GB8328916D0 (en) * | 1983-10-28 | 1983-11-30 | Castex Prod | Pharmaceutical pellet |
| IN162525B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 1984-02-08 | 1988-06-04 | Pfizer | |
| FR2560768A1 (fr) * | 1984-03-07 | 1985-09-13 | Crb Virbac Sa | Dispositif a liberation programmee |
| US5000957A (en) * | 1984-03-19 | 1991-03-19 | Alza Corporation | Dispenser comprising hydrophilic osmopolymer |
| NZ212100A (en) * | 1984-06-02 | 1988-07-28 | Castex Prod | Rumen bolus; outer casing sheds in segments |
| GB2164557B (en) * | 1984-09-15 | 1987-10-28 | Standard Telephones Plc | Rumen bolus of soluble glass |
| US4735804A (en) * | 1985-05-10 | 1988-04-05 | Merck & Co., Inc. | Drug delivery device which can be retained in the stomach for a controlled period of time |
| DE3680024D1 (de) * | 1985-05-10 | 1991-08-08 | Merck & Co Inc | Abgabesystem fuer arzneimittel, das waehrend einer kontrollierten zeitspanne im magen zurueckgehalten werden kann. |
| US5618547A (en) * | 1985-05-20 | 1997-04-08 | British Technology Group Limited | Control of ectoparasites |
| US4767627A (en) * | 1985-05-29 | 1988-08-30 | Merck & Co., Inc. | Drug delivery device which can be retained in the stomach for a controlled period of time |
| US4758436A (en) * | 1985-05-29 | 1988-07-19 | Merck & Co., Inc. | Drug delivery device which can be retained in the stomach for a controlled period of time |
| US4717568A (en) * | 1985-08-09 | 1988-01-05 | Alza Corporation | Laminar arrangement for increasing delivery of beneficial agent from dispenser |
| US4710191A (en) * | 1985-12-16 | 1987-12-01 | Jonergin, Inc. | Therapeutic device for the administration of medicaments |
| US5407685A (en) * | 1986-02-06 | 1995-04-18 | Steris Corporation | Controlled oxygen/anti-microbial release films |
| US4808412A (en) * | 1987-06-11 | 1989-02-28 | Eastman Kodak Company | Rumen-stable compositions |
| GB8815968D0 (en) * | 1988-07-05 | 1988-08-10 | Pfizer Ltd | Veterinary devices |
| US5141810A (en) * | 1988-10-04 | 1992-08-25 | Pfizer Inc. | Means for constraining a rumen drug delivery device in a rolled configuration |
| NZ228382A (en) * | 1989-03-17 | 1992-08-26 | Carter Holt Harvey Plastic Pro | Drug administering coil-like device for insertion in body cavity of animal |
| JPH0595483U (ja) * | 1992-05-25 | 1993-12-27 | 健順 藤原 | ミシンの突起付き定規 |
| AU702746B2 (en) * | 1995-09-20 | 1999-03-04 | Cochlear Limited | Bioresorbable polymer use in cochlear and other implants |
| FR2754711B1 (fr) * | 1996-10-21 | 1999-01-29 | Vandamme Thierry | Dispositif de liberation avec effet retard d'une substance active, notamment veterinaire |
| DE19715794C1 (de) * | 1997-04-16 | 1998-12-03 | Roehm Gmbh | Laminare Arzneiform und Verfahren zu ihrer Herstellung |
| US6096328A (en) * | 1997-06-06 | 2000-08-01 | The Procter & Gamble Company | Delivery system for an oral care substance using a strip of material having low flexural stiffness |
| US6146655A (en) * | 1997-08-29 | 2000-11-14 | Softy-Flex Inc. | Flexible intra-oral bandage and drug delivery system |
| MD1567G2 (ro) * | 1998-01-27 | 2001-06-30 | "Р.И.Ф." А.О. | Procedeu de preparare a cataplasmei de muştar, linie pentru executarea ei şi cataplasmă de muştar, preparată prin acest procedeu |
| MD1573G2 (ro) * | 1999-01-19 | 2001-06-30 | "Р.И.Ф." А.О. | Procedeu de ambalare a cataplasmei de muştar |
| CZ20014709A3 (cs) | 1999-07-02 | 2002-09-11 | The Procter & Gamble Company | Dávkovací systém pro dodávání látky ústní hygieny do dutiny ústní a způsob dávkování |
| DE19946822A1 (de) * | 1999-09-30 | 2001-04-26 | Lohmann Therapie Syst Lts | Wirk- und/oder Hilfsstoffe enthaltende Zubereitung mit steuerbarer Freisetzung dieser Stoffe, sowie ihre Verwendung und Herstellung |
| US20040219186A1 (en) * | 2001-08-16 | 2004-11-04 | Ayres James W. | Expandable gastric retention device |
| FR2839645B1 (fr) * | 2002-05-15 | 2005-08-05 | Backert Marie Elisabeth Cuine | Systeme multilamellaire pour l'administration de substances actives (en particulier des medicaments) par ingestion par la voie orale |
| WO2003099263A1 (de) * | 2002-05-24 | 2003-12-04 | Agfa-Gevaert | Wirkstoff enthaltende, zumindest teilweise abbaubare folien und verfahren zuderen herstellung |
| US8524200B2 (en) | 2002-09-11 | 2013-09-03 | The Procter & Gamble Company | Tooth whitening products |
| US20080089933A1 (en) | 2006-10-16 | 2008-04-17 | Amir Alon | Device and method for reducing calorie intake |
| US8095268B2 (en) | 2004-10-29 | 2012-01-10 | Bose Corporation | Active suspending |
| US7699863B2 (en) * | 2005-03-01 | 2010-04-20 | Tulip Medical Ltd. | Bioerodible self-deployable intragastric implants |
| US7785291B2 (en) * | 2005-03-01 | 2010-08-31 | Tulip Medical Ltd. | Bioerodible self-deployable intragastric implants |
| US8722066B2 (en) | 2011-03-29 | 2014-05-13 | Primigenia, LLC | Devices and methods for weight control and weight loss |
| WO2012149326A1 (en) | 2011-04-29 | 2012-11-01 | Massachusetts Institute Of Technology | Layer processing for pharmaceuticals |
| BR112014021678B1 (pt) * | 2012-03-07 | 2022-05-03 | Global Life Sciences Solutions Usa Llc | Sistema de reator pressurizado |
| US10507127B2 (en) | 2012-06-07 | 2019-12-17 | Epitomee Medical Ltd. | Expandable device |
| MX361101B (es) | 2012-10-17 | 2018-11-27 | Procter & Gamble | Tira para el suministro de un activo para el cuidado bucal y métodos para aplicar activos para el cuidado bucal. |
| ES2926480T3 (es) | 2013-12-05 | 2022-10-26 | Epitomee Medical Ltd | Dispositivos y sistemas retentivos para la liberación in situ de principios activos farmacéuticos |
| WO2015179461A1 (en) | 2014-05-20 | 2015-11-26 | Massachusetts Institute Of Technology | Plasticity induced bonding |
| WO2022089588A1 (zh) * | 2020-10-30 | 2022-05-05 | 南京三迭纪医药科技有限公司 | 胃滞留药物剂型 |
| JP2023553202A (ja) | 2020-12-08 | 2023-12-20 | ルミナント バイオテク コーポレーション リミテッド | 動物に物質を送達するための装置および方法の改善 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2625158A (en) * | 1945-12-15 | 1953-01-13 | John W Lee | Subcutaneous medication |
| US3545439A (en) * | 1968-01-04 | 1970-12-08 | Upjohn Co | Medicated devices and methods |
| AU449029B2 (en) * | 1969-08-28 | 1974-04-17 | Commonwealth Scientific And Industrial Research Organisation | Device for administration to ruminants |
| US3625214A (en) * | 1970-05-18 | 1971-12-07 | Alza Corp | Drug-delivery device |
| US3832252A (en) * | 1970-09-29 | 1974-08-27 | T Higuchi | Method of making a drug-delivery device |
| US3903880A (en) * | 1972-08-17 | 1975-09-09 | Alza Corp | Intrauterine device for managing the reproductive process |
| GB1333576A (en) * | 1970-10-21 | 1973-10-10 | Alza Corp | Sustained release drug dosage device |
| US3892238A (en) * | 1971-09-16 | 1975-07-01 | Abbott Lab | Drug supporting anchor |
| US3796217A (en) * | 1972-03-10 | 1974-03-12 | Hydr Med Sciences Inc | Drug release system |
| GB1425550A (en) * | 1973-04-25 | 1976-02-18 | Alza Corp | Device for releasing active agent and process for producing the same |
| GB1471465A (en) * | 1974-06-04 | 1977-04-27 | Groves H | Vaginal medicator |
| ZA767136B (en) * | 1975-12-15 | 1977-10-26 | Hoffmann La Roche | Novel dosage form |
| US4029757A (en) * | 1975-12-15 | 1977-06-14 | Hoffmann-La Roche Inc. | Manufacture of pharmaceutical unit dosage forms |
| US4031200A (en) * | 1975-12-15 | 1977-06-21 | Hoffmann-La Roche Inc. | Manufacture of pharmaceutical unit dosage forms |
| US4055178A (en) * | 1976-03-10 | 1977-10-25 | Harrigan Roy Major | Drug delivery device for preventing contact of undissolved drug with the stomach lining |
| US4180558A (en) * | 1978-08-21 | 1979-12-25 | Hoffmann-La Roche Inc. | Unit dosage forms |
| GB1601923A (en) * | 1977-06-09 | 1981-11-04 | Beecham Group Ltd | Sustained release compositions |
| DE2966275D1 (en) * | 1978-11-07 | 1983-11-10 | Beecham Group Plc | Device for oral administration to a ruminant animal |
-
1979
- 1979-11-05 DE DE7979302445T patent/DE2966275D1/de not_active Expired
- 1979-11-05 AU AU52510/79A patent/AU528190B2/en not_active Ceased
- 1979-11-05 EP EP79302445A patent/EP0010987B1/en not_active Expired
- 1979-11-05 DK DK468379A patent/DK156375C/da active
- 1979-11-06 IE IE2127/79A patent/IE48982B1/en not_active IP Right Cessation
- 1979-11-06 NZ NZ192048A patent/NZ192048A/xx unknown
- 1979-11-06 CA CA000339311A patent/CA1146821A/en not_active Expired
- 1979-11-07 US US06/092,178 patent/US4268497A/en not_active Expired - Lifetime
- 1979-11-07 JP JP14341779A patent/JPS5588759A/ja active Granted
- 1979-11-07 ZA ZA00795997A patent/ZA795997B/xx unknown
-
1980
- 1980-12-09 US US06/214,778 patent/US4308250A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US4268497A (en) | 1981-05-19 |
| IE792127L (en) | 1980-05-07 |
| NZ192048A (en) | 1982-03-09 |
| AU528190B2 (en) | 1983-04-21 |
| DK468379A (da) | 1980-05-08 |
| EP0010987A1 (en) | 1980-05-14 |
| ZA795997B (en) | 1980-10-29 |
| DK156375C (da) | 1990-03-05 |
| US4308250A (en) | 1981-12-29 |
| AU5251079A (en) | 1980-05-15 |
| JPS6223576B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1987-05-23 |
| JPS5588759A (en) | 1980-07-04 |
| EP0010987B1 (en) | 1983-10-05 |
| DK156375B (da) | 1989-08-14 |
| IE48982B1 (en) | 1985-06-26 |
| DE2966275D1 (en) | 1983-11-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1146821A (en) | Sustained drug release device | |
| US4228149A (en) | Sustained release compositions | |
| ES2355099T3 (es) | Dispositivo osmótico dentro de un dispositivo osmótico. | |
| US8840919B2 (en) | Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films | |
| US9561182B2 (en) | Edible films for administration of medicaments to animals, methods for their manufacture and methods for their use for the treatment of animals | |
| TW492880B (en) | Pressure-sensitive adhesive transdermal drug delivery system containing low molecular weight drugs which are liquid at room temperatures, and method of providing the same | |
| CA1336727C (en) | Flexible, hydrophilic gel film, the process for its production and the use of it | |
| AU2002250904B2 (en) | Mucoadhesive dispersible pharmaceutical preparation for active-agent dosing in veterinary and human medicine | |
| JP6525165B2 (ja) | 乱用および誤用抑止経皮システム | |
| CZ20012566A3 (cs) | Jednotková dávka a způsob přípravy jednotkové dávky pro slizniční podávání | |
| NO178426B (no) | Legemiddelavgivelsesanordning for gastrisk kontrollert medikamentavgivelse | |
| BRPI0708068A2 (pt) | pelìculas bucais passíveis de desintegração | |
| JP2008519075A (ja) | 非ゼラチン軟質カプセルシステム | |
| JPS5948409A (ja) | 矯正的歯牙移動促進剤 | |
| PT86828B (pt) | Processo para a preparacao de adesivos farmaceuticos | |
| US20200289402A1 (en) | Pouch-type orally dissolving films with high active ingredient concentration | |
| EP0021758B1 (en) | Veterinary preparations for ruminant animals | |
| JPH05502894A (ja) | 放出制御性製剤及び方法 | |
| JPS58213709A (ja) | 歯肉粘膜用貼付剤 | |
| CA1330744C (en) | Veterinary devices | |
| Singh et al. | Formulation and evaluation of rapidly disintegrating film of levocetrizine hydrochloride | |
| AU619481B2 (en) | Oral magnesium and potassium compositions and use | |
| KR860000070A (ko) | 종양 발육억제 조성물 | |
| PL145663B1 (en) | Method of obtaining sustained-action drug tablets | |
| HK40085268A (en) | Abuse and misuse deterrent transdermal systems |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |